Targeted delivery of toxins and enzymes by antibodies and growth factors

This publication has 21 references indexed in Scilit:

• Phase I/II Study of Murine Monoclonal Antibody-Ricin A Chain (XOMAZYME-Mel) Immunoconjugate plus Cyclosporine A in Patients with Metastatic Melanoma
  Journal of Immunotherapy, 1993
• T lymphocyte killing by a xanthine-oxidase-containing immunotoxin
  Cancer Immunology, Immunotherapy, 1992
• Penetration of anti-melanoma immunotoxin into multicellular tumor spheroids and cell kill effects
  Cancer Immunology, Immunotherapy, 1992
• Structural features of the antibody-A chain linkage that influence the activity and stability of ricin A chain immunotoxins
  Bioconjugate Chemistry, 1992
• A combination of two immunotoxins exerts synergistic cytotoxic activity against human breast-cancer cell lines
  International Journal of Cancer, 1992
• Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin
  The Lancet, 1992
• The specific cytotoxicity of immunoconjugates containing blocked ricin is dependent on the residual binding capacity of blocked ricin: Evidence that the membrane binding and A-chain translocation activities of ricin cannot be separated
  Biochemical and Biophysical Research Communications, 1992
• Photoactivation of toxin conjugates
  Bioconjugate Chemistry, 1992
• Combined Antitumor Therapy with the Chemotherapeutic Drug Doxorubicin and an Anti-Transferrin Receptor Immunotoxin, In Vitro and In Vivo Studies
  Journal of Immunotherapy, 1992
• Properties of chimeric toxins with two recognition domains: interleukin 6 and transforming growth factor .alpha. at different locations in Pseudomonas exotoxin
  Bioconjugate Chemistry, 1992